Starting in the fall 2017 semester, Cornell University will offer a Master of Public Health degree with a focus on epidemiology, infectious disease, food systems and sustainability.
In the June 10 Olin Lecture, Christopher Oechsli, president and CEO of The Atlantic Philanthropies, discussed the impact Charles F. Feeney '56 has had at Cornell and around the world.
Entering a new age in education, Dan Huttenlocher, the dean and vice provost of Cornell Tech, explained the new school's charm and allure as it begins to bloom in New York City.
A gift from Andrew ’71 and Ann Tisch to Cornell University and the American Technion Society has created an endowed professorship at the Joan & Irwin Jacobs Technion-Cornell Institute at Cornell Tech.
Metastatic prostate cancer patients respond better to treatment when they switch to different drugs in the absence of an optimal initial response: new research from Weill Cornell Medicine.
A drug that recruits immune cells to fight an aggressive form of lymphoma appears to be more effective than chemotherapy, according to new research from Weill Cornell Medicine.
The steroid dexamethasone could potentially deter the growth of a prostate cancer subtype previously thought to be difficult to treat with medications.
Researchers from Weill Cornell Medicine and the U.S. government have created a checklist to identify patients who develop a common and potentially fatal secondary meningitis infection.
